Inherited diseases involving G proteins and G protein-coupled receptors

被引:168
作者
Spiegel, AM [1 ]
Weinstein, LS [1 ]
机构
[1] NIDDK, NIH, Bethesda, MD 20892 USA
来源
ANNUAL REVIEW OF MEDICINE | 2004年 / 55卷
关键词
signal transduction; gain- and loss-of-function mutations; hormone resistance;
D O I
10.1146/annurev.med.55.091902.103843
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Heterotrimeric G proteins couple seven-transmembrane receptors for diverse extracellular signals to effectors that generate intracellular signals altering cell function. Mutations in the gene encoding the a subunit of the G protein-coupling receptors to stimulation of adenylyl cyclase cause developmental abnormalities of bone, as well as hormone resistance (pseudohypoparathyroidism caused by loss-of-function mutations) and hormone hypersecretion (McCune-Albright syndrome caused by gain-of-function mutations). Loss- and gain-of-function mutations in genes encoding G protein-coupled receptors (GPCRs) have been identified as the cause of an increasing number of retinal, endocrine, metabolic, and developmental disorders. GPCRs comprise an evolutionarily conserved gene superfamily (1). By coupling to heterotrimeric G proteins, GPCRs transduce a wide variety of extracellular signals including monoamine, amino acid, and nucleoside neurotransmitters, as well as photons, chemical odorants, divalent cations, hormones, lipids, peptides and proteins. Following a brief overview of G protein-coupled signal transduction, we review the growing body of evidence that mutations in genes encoding GPCRs and G proteins are an important cause of human disease.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 50 条
  • [1] Paternal uniparental isodisomy of chromosome 20q -: and the resulting changes in GNAS1 methylation -: as a plausible cause of pseudohypoparathyroidism
    Bastepe, M
    Lane, AH
    Yüppner, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) : 1283 - 1289
  • [2] BERSON EL, 2002, PRINCIPLES PRACTICE, P2262
  • [3] Molecular tinkering of G protein-coupled receptors: an evolutionary success
    Bockaert, J
    Pin, JP
    [J]. EMBO JOURNAL, 1999, 18 (07) : 1723 - 1729
  • [4] An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gβ3 C825T polymorphism
    Brand, E
    Wang, JG
    Herrmann, SM
    Staessen, JA
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (04) : 729 - 737
  • [5] The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia
    Calvi, LM
    Schipani, E
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) : 545 - 554
  • [6] INCREASED EXPRESSION OF THE C-FOS PROTOONCOGENE IN BONE FROM PATIENTS WITH FIBROUS DYSPLASIA
    CANDELIERE, GA
    GLORIEUX, FH
    PRUDHOMME, J
    STARNAUD, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) : 1546 - 1551
  • [7] Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease
    Carrasquillo, MM
    McCallion, AS
    Puffenberger, EG
    Kashuk, CS
    Nouri, N
    Chakravarti, A
    [J]. NATURE GENETICS, 2002, 32 (02) : 237 - 244
  • [8] Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia
    Collins, MT
    Chebli, C
    Jones, J
    Kushner, H
    Consugar, M
    Rinaldo, P
    Wientroub, S
    Bianco, P
    Robey, PG
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (05) : 806 - 813
  • [9] Somatic and germline mutations of the TSH receptor and thyroid diseases
    Corvilain, B
    Van Sande, J
    Dumont, JE
    Vassart, G
    [J]. CLINICAL ENDOCRINOLOGY, 2001, 55 (02) : 143 - 158
  • [10] Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
    Covic, L
    Misra, M
    Badar, J
    Singh, C
    Kuliopulos, A
    [J]. NATURE MEDICINE, 2002, 8 (10) : 1161 - 1165